Corteva Inc. (CTVA)

NYSE: CTVA · USD

$11.3

-0.31 (-2.7%)· Recorded snapshot

英語版にフォールバックJA

翻訳中のため英語版を表示しています

このレポートはまだ翻訳されていません。翻訳キューが追いついたら数分後に更新してください。

StockMarketAgent Research · Analyzed 2026-10-03

Our latest published analysis: CTVA rated Strong Buy

Corteva Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$51.7 / share

Potential value

$73.7 / share

Upside to FV

+334.0%

from $11.3

Moat

7.2/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$8.0B
Shares out	667.2M
P/E (forward)	19.1x
Dividend	$0.13 (1.16%)
Volume	14,482,667
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

P/E (forward): 19.1x
Market cap: $8.0B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$15.66B	$17.46B	$17.23B	$16.91B	$17.40B	+2.7%
Gross profit	$6.44B	$7.02B	$17.23B	$7.38B	$8.23B	+6.3%
Operating income	$2.38B	$1.51B	$941.0M	$1.51B	$1.87B	-5.8%
Net income	$1.76B	$1.15B	$735.0M	$907.0M	$1.09B	-11.2%
EPS (diluted)	$2.37	$1.58	$1.03	$1.30	$1.60	-9.4%
EBITDA	$3.62B	$2.73B	$941.0M	$2.74B	$3.07B	-4.0%
R&D	$1.19B	$1.22B	$1.34B	$1.40B	$1.47B	+5.6%
SG&A	$3.21B	$3.17B	$3.18B	$3.20B	$3.49B	+2.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	ホールド
ALB	Albemarle Corporation	11.4B	198.9x	1.9x	4.1%	+12.8%	+1.9%	ホールド
ANET	Arista Networks Inc.	235.7B	59.1x	22.4x	284.8%	+32.0%	+19.7%	売り
APD	Air Products and Chemicals, Inc.	68.3B	—	5.4x	8.9%	+5.2%	+23.1%	ホールド
AVY	Avery Dennison Corporation	13.7B	19.8x	1.5x	15.1%	+3.3%	+1.6%	ホールド
BALL	Ball Corporation	16.7B	18.0x	1.2x	8.7%	+2.3%	+28.3%	買い

Base and Bull scenarios

Base60%

Price target

$51.73

+334.0% from spot

Corteva executes on its core operational strategy: Seed segment trait out-licensing continues tracking three years ahead of plan, offsetting broader crop price softening. Crop Protection new patented products touch $2.0B in FY2026, neutralizing mid-single-digit price declines in legacy chemistries. Latin American growth moderates to low-single-digit rates due to tight farmer credit. Cash generation remains robust, funding steady share repurchases and balance sheet health.

Revenue grows from $18,116M in FY2026 to $20,318M in FY2030 (2.5%-4.1% annual growth)
Operating margin expands from 15.2% in FY2026 to 16.2% by FY2030
Diluted EPS tracks consensus of $3.76 in FY2026 and $3.23 in FY2027
Net reinvestment rate scales from 18.0% to 25.0% of NOPAT
Terminal multiple of 15.5x forward P/E and perpetual growth rate of 2.50%

Bull15%

Price target

$73.70

+518.3% from spot

Proprietary seed trait licensing expands ahead of schedule across third-party seed networks, driving substantial margin expansion. Patented crop protection molecules and biologicals exceed commercial launch targets, capturing market share from distressed commodity competitors. Brazilian safrinha corn planted area expands briskly, lifting Latin American revenue growth above historical trend and driving diluted EPS to the high end of analyst estimates.

Seed trait out-licensing royalties exceed multi-year targets by more than three years
Crop Protection new product revenue exceeds $2.5B while biologicals take share from distressed peers
Brazilian planted acreage expands briskly year over year driving regional revenue growth above trend
Consolidated operating margin reaches 17.5% and FY2026 diluted EPS achieves consensus high of $4.02

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($51.73). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
5.5%	$56.4	$58.6	$61.2	$64.2	$67.7
6.0%	$52.0	$53.6	$55.5	$57.6	$60.1
6.5%	$48.4	$49.7	$51.7	$52.7	$54.6
7.0%	$45.4	$46.5	$47.6	$48.9	$50.3
7.5%	$43.0	$43.8	$44.7	$45.7	$46.8

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E46.6

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CTVA indicators

Market & fundamental data

Available fields

149

Groups with data

Currency

USD

Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001755672
Company name	Corteva, Inc.
Country	United States
Country code	US
CUSIP number	22052L104
Earnings date	2026-11-11
Earnings time	amc
Employees	21,500
Employees change	-500
Employees growth	-2.27%
Enterprise value	$10.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Agricultural Inputs
Is primary listing	Yes
Is SPAC	No
ISIN number	US22052L1044
Last 10-K release date	2026-02-12
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$7.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$11.32
Price currency	USD
Sector	Materials
SIC code	0100
Stock price date	2026-10-28
Symbol	CTVA
U.S. state	Indiana
Website	https://www.corteva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
EV/FCF	16.65x
FCF / EV yield	6%
FCF yield	8.27%
Forward EV/Sales	1.32x
Forward P/E	12.07x
Forward P/S	0.96x
Industry forward P/E	13.11x
Industry P/E	45.74x
P/B ratio	0.96x
P/FCF ratio	12.09x
PEG ratio	1.43x
Price / tangible book value	3.97x
Sector forward P/E	15.02x
Sector P/E	22.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
FCF margin	12.66%
Profitable quarters	2
Profitable years	6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-20.4%
EPS growth years	2
Net income growth (QoQ)	-21.18%
Net income growth years	2
Revenue growth (QoQ)	-1.86%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-582M
FCF per share	$0.94
Free cash flow	$629M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$12.14
Debt / equity	0.57
Debt / FCF	7.59
Goodwill	$5.2B
Long-term assets	$9.9B
Long-term liabilities	$4B
Net cash (debt)	$-2.9B
Net cash / market cap	-37.72%
Net debt / equity	0.34
Net debt / FCF	4.56
Piotroski F-Score	0
Property, plant and equipment	$1.7B
Shareholders' equity	$8.3B
Tangible book value	$1.9B
Tangible book value per share	$2.88
Total assets	$19.7B
Total cash	$1.9B
Total debt	$4.8B
Total liabilities	$11.3B
WACC	4.56%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$9.8B
Current liabilities	$7.3B
Current ratio	1.33
Net working capital	$3.6B
Quick ratio	0.89
Working capital	$2.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	24.74%
Dividend growth (3Y)	12.09%
Dividend growth (5Y)	10.09%
Dividend growth years	6
Dividend payment date	2026-12-15
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	$0.13
Dividend yield	1.16%
Ex-dividend date	2026-12-01
FCF payout ratio	13.9%
Last dividend	$0.05
Shareholder yield	1.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-2.67%
1W price change	-12.75%
1W total return	-12.75%
52-week high	$14.62
52-week high date	2026-10-07
52-week low	$11.25
52-week low date	2026-10-28
All-time high	$14.62
All-time high date	2026-10-07
All-time low	$11.25
All-time low date	2026-10-28
Average true range (ATR)	$0.75
Average volume	36.5M
Beta (1Y)	4.52
Beta (5Y)	0.58
Change from 52-week high	-22.57%
Change from 52-week low	0.62%
Change from all-time high	-23.02%
Change from all-time low	0.27%
Change from open	-2.58%
Day's gap	-0.09%
Dollar volume	$163.9M
High price	$11.72
Low price	$11.25
Monthly RSI	0
Open price	$11.62
Position in 52-week range	14.89%
Premarket change	0%
Premarket close	$11.63
Premarket price	$11.63
Previous close	$11.63
Relative volume	0.4
RSI	37.29
Sharpe ratio	-2.03
Sortino ratio	-3.06
Volume	14.5M
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	667M
Float percentage	99.96%
Shares change (QoQ)	-0.98%
Shares held by insiders	0.04%
Shares held by institutions	0.09%
Shares outstanding	667.2M
Short % of float	3.24%
Short % of shares	3.24%
Short ratio	4.5 days

Deeper analysis on CTVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this CTVA report

What is the latest published CTVA stock rating?

Corteva Inc. is shown with Strong Buy in the latest published report, analyzed 2026-10-03. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CTVA analysis?

The full latest published report, analyzed 2026-10-03, lives at /stocks/CTVA/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for CTVA?

The latest published report analyzed 2026-10-03 gives CTVA a fair value of USD 52 and a potential value of USD 74. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the CTVA page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-03). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Strong BuyCTVA · Fair value $51.7+334.0%

Read full analysis →

Category	Score	Reading
Valuation	9.5
Management	7.5
Balance Sheet	8.0
Profitability	3.5
Revenue Growth	2.5
Risk Assessment	8.5
Competitive Moat	7.2
Earnings Quality	7.5
Capital Efficiency	5.5

Corteva Inc. (CTVA)

Our latest published analysis: CTVA rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Latest news · CTVA

Valuation

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All CTVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CTVA

Frequently asked questions

レーティング履歴